Pluri Inc. Severance Costs
Pluri Inc. (PLUR) reported Severance Costs of $680.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts1 · last filed 2026-09-10
- Pluri Inc. severance costs for fiscal 2026 was $680.00K, a 2.56% increase from fiscal 2025.
- Pluri Inc. severance costs for fiscal 2025 was $663.00K, a 4.91% increase from fiscal 2024.
- Pluri Inc. severance costs for fiscal 2024 was $632.00K, a 13.66% decline from fiscal 2023.
- Pluri Inc. severance costs for fiscal 2023 was $732.00K, a 12.34% decline from fiscal 2022.
| Period end | Severance Costs 12 month |
|---|---|
| 2026-06-30 | $680.00K 10-K · filed 2026-09-10 |
| 2025-06-30 | $663.00K 10-K · filed 2026-09-10 |
| 2024-06-30 | $632.00K 10-K · filed 2025-09-17 |
| 2023-06-30 | $732.00K 10-K · filed 2024-09-18 |
| 2022-06-30 | $835.00K 10-K · filed 2023-09-12 |
| 2021-06-30 | $748.00K 10-K · filed 2022-09-21 |
| 2020-06-30 | $604.00K 10-K · filed 2021-09-13 |
| 2019-06-30 | $632.00K 10-K · filed 2020-09-10 |
| 2018-06-30 | $822.00K 10-K · filed 2020-09-10 |
| 2017-06-30 | $524.00K 10-K · filed 2019-09-12 |
| 2013-06-30 | $329.00K 10-K · filed 2013-09-11 |
| 2012-06-30 | $275.00K 10-K · filed 2013-09-11 |
| 2011-06-30 | $225.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |